CD73 mediated host purinergic metabolism in intestine contributes to the therapeutic efficacy of a novel mesenchymal-like endometrial regenerative cells against experimental colitis

BACKGROUND: The disruption of intestinal barrier functions and the dysregulation of mucosal immune responses, mediated by aberrant purinergic metabolism, are involved in the pathogenesis of inflammatory bowel diseases (IBD). A novel mesenchymal-like endometrial regenerative cells (ERCs) has demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Bo, Ren, Shao-hua, Wang, Zhao-bo, Wang, Hong-da, Zhang, Jing-yi, Qin, Hong, Zhu, Yang-lin, Sun, Cheng-lu, Xu, Yi-ni, Li, Xiang, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167049/
https://www.ncbi.nlm.nih.gov/pubmed/37180168
http://dx.doi.org/10.3389/fimmu.2023.1155090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167049/
https://www.ncbi.nlm.nih.gov/pubmed/37180168
http://dx.doi.org/10.3389/fimmu.2023.1155090

Ejemplares similares